Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ribavirin in chronic hepatitis C: past and future.
Loustaud-Ratti V, Rousseau A, Marquet P, Denis F, Alain S. Loustaud-Ratti V, et al. Expert Rev Anti Infect Ther. 2009 Apr;7(3):249-53. doi: 10.1586/eri.09.5. Expert Rev Anti Infect Ther. 2009. PMID: 19344238 No abstract available.
Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment.
Loustaud-Ratti V, Carrier P, Rousseau A, Maynard M, Babany G, Alain S, Trépo C, De Ledinghen V, Bourlière M, Pol S, Di Martino V, Zarski JP, Pinta A, Sautereau D, Marquet P; OPTIRIB group. Loustaud-Ratti V, et al. Dig Liver Dis. 2011 Nov;43(11):850-5. doi: 10.1016/j.dld.2011.04.002. Epub 2011 May 18. Dig Liver Dis. 2011. PMID: 21596633 Review.
Ribavirin therapeutic drug monitoring: why, when and how?
Stanke-Labesque F, Loustaud-Ratti V, Babany G, Gagnieu MC, Marquet P; French Ribavirin Group OPTIRIB. Stanke-Labesque F, et al. Fundam Clin Pharmacol. 2010 Aug;24(4):401-6. doi: 10.1111/j.1472-8206.2009.00778.x. Epub 2009 Sep 24. Fundam Clin Pharmacol. 2010. PMID: 19788564 Review.
Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.
Loustaud-Ratti V, Maynard M, Thevenon S, Pradat P, Rousseau A, Alain S, Deny P, Gagnieu MC, Tran A, Dao T, Silvain C, Lunel-Fabiani F, Picard N, Zublena I, Marquet P, Trepo C; RIBAJUSTE Group. Loustaud-Ratti V, et al. Ther Drug Monit. 2016 Dec;38(6):684-692. doi: 10.1097/FTD.0000000000000332. Ther Drug Monit. 2016. PMID: 27559840 Clinical Trial.
Ribavirin: Past, present and future.
Loustaud-Ratti V, Debette-Gratien M, Jacques J, Alain S, Marquet P, Sautereau D, Rousseau A, Carrier P. Loustaud-Ratti V, et al. World J Hepatol. 2016 Jan 18;8(2):123-30. doi: 10.4254/wjh.v8.i2.123. World J Hepatol. 2016. PMID: 26807208 Free PMC article. Review.
Seroreversion from hepatitis C after needlestick injury.
Alain S, Loustaud-Ratti V, Dubois F, Bret MD, Rogez S, Vidal E, Denis F. Alain S, et al. Clin Infect Dis. 2002 Mar 1;34(5):717-9. doi: 10.1086/338405. Clin Infect Dis. 2002. PMID: 11823960 No abstract available.
190 results